The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

155 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-26

Study Completion Date

2024-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present observational study is to evaluate and describe the evolution over time of the fatigue and the quality of life of patients with bone tumor, in Rizzoli Orthopedic Institute, Chemotherapy ward, during the chemotherapy treatment and in the first phase of follow-up and to identify possible prognostic factors. Such knowledge is a necessary precondition for identifying patients and the periods most at risk due to the onset of fatigue, so as to be able to hypothesize adequate containment strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fatigue Before and After Exercise in Patients With Advanced Cancer Stage

NCT01581216

Fatigue

UNKNOWN NA

A Feasibility Study in Chronically Fatigued Cancer Survivors

NCT04931407

Fatigue Lymphoma

COMPLETED NA

Cancer-related Fatigue Among Patients Receiving Home-based Palliative Care

NCT06498193

to Investigate the Level of Fatigue Among Terminal Cancer Patients Receiving Home-based Hospice Care

ACTIVE_NOT_RECRUITING

Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment

NCT01546233

Lung Cancer

COMPLETED

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

NCT04557137

Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fatigue syndrome It is a clinical condition, linked to the oncological pathology, extremely widespread and in patients undergoing chemotherapy and / or radiotherapy it is common in 80% of patients. Literature stress the need for systematic studies in cancer populations with different types of cancer and at different stages of the disease using patient-oriented fatigue assessment tools. The Brief Fatigue Inventory (BFI) is one of the scales used precisely in the evaluation of this syndrome and has proved to be a reliable and easy to use tool, also validated in Italian. Several authors have also shown that reduced physical activity and a worse quality of life are associated with fatigue, particularly in young patients.Several authors describe the experience of 11 new sarcoma patients undergoing chemotherapy treatment. Fatigue had been described as the prevalent symptom and was related to a worse quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue Syndrome, Chronic Bone Tumor Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

assessment scales (BFI, QLQ, TESS)

the patient's Fatigue will be measured during the treatment period with antiblastic drugs and part of the followup period. To this end the BFI scale validated in Italian will be used (Mendoza et al 1999; Catania et al, 2013) which includes 9 items with a score for each of 0 to 10 and a consequent total score from 0 to 90. The measurement will take place in 4 times: the day of enrollment, 6 months, 12 months and 24 months after enrollment.the quality of life of patients measured by the EORTC QLQ C-30 scale (Aaronson et al, 1993) and the level of autonomy measured by the TESS scale (Davis et al, 1996) in 4 steps: the enrollment day , at 6 months, at 12 months and at 24 months from enrollment.

Intervention Type OTHER